In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Recommanded Product: 2379-56-8, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 2379-56-8, name is 6-Nitroquinoxaline-2,3-dione. In an article£¬Which mentioned a new discovery about 2379-56-8
Glycine receptor antagonists and the use thereof
Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease and Down’s syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, inducing anesthesia and treating psychosis are disclosed by administering to an animal in need of such treatment a compound having high affinity for the glycine binding site, lacking PCP side effects and which crosses the blood brain barrier of the animal. Also disclosed are novel 1,4-dihydroquinoxaline-2,3-diones, and pharmaceutical compositions thereof. Also disclosed are highly soluble ammonium salts of 1,4-dihydroquinoxaline-2,3-diones.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 2379-56-8, help many people in the next few years.Recommanded Product: 2379-56-8
Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1695 | ChemSpider